Mark Tuszynski

Mark Tuszynski

Company: University of California, School of Medicine

Job title: Professor


A Phase 1 Clinical Trial of AAV2-BDNF Gene Therapy in Alzheimer’s Disease and MCI 12:30 pm

Prior growth factor gene therapy experience in Alzheimer’s disease Preclinical rationale for translation to the clinic Clinical updateRead more

day: Day One: Track B AM

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.